Rapamycin has long been an FDA-approved drug used as an antifungal, and immunosuppressant. However, its use in bio-hacking ...

Physician and seasoned life sciences investor with more than two decades of experience across clinical practice, ...

New Drug Application (NDA) for QTORIN™ rapamycin for the treatment of microcystic lymphatic malformations (microcystic LMs) ...

Detailed price information for Palvella Therapeutics Inc (PVLA-Q) from The Globe and Mail including charting and trades.

The Rowe family dog Ralph was one of many canines with dementia who participated in a study of rapamycin. Scientists were able to gain new insight into the drug's potential as a treatment by studying ...

Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year survival below 30% ...

Researchers at the University of Arizona R. Ken Coit College of Pharmacy will begin a double-blind, randomized Phase 3 ...

Longevity experts are turning to technologies and supplements to help extend their lifespan, but how likely are their methods ...

Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year ...

The Dog Aging Project is working to help dogs live longer, healthier lives. The research results may help humans age well, too.

The University of Texas at San Antonio Health Science Center UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio) is launching a multi-phase ...

As has been the case for the past few years, financing for small- and micro-cap biotech companies remains challenging. The ...